LCID
Lucid Group, Inc.
LCID has a slight edge over MBLY overall, supported by stronger fundamentals and stronger modeled upside.
MBLY
Mobileye Global Inc.
MBLY has lower modeled downside risk, despite its lower overall score.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MBLY Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Stable | |
| Strong |
MBLY's balance sheet is currently strong, and its revenue and cash flow are stable, but its profitability is weak.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
MBLY PE Valuation
MBLY has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
MBLY Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for MBLY, with profitability improving. However, they disagree widely on these estimates.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over MBLY on earnings, with more consistent year-over-year improvement.
MBLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.41 | — |
| Q3 2026 | -$4.94 | -$4.52 |
| Q2 2026 | -$4.98 | -$1.33 |
| Q1 2026 | -$5.03 | -$1.35 |
| Q4 2025 | -$0.48 | +$3.34 |
| Q3 2025 | -$0.42 | +$3.22 |
| Q2 2025 | -$3.65 | -$3.38 |
| Q1 2025 | -$3.68 | -$3.48 |
| Q4 2024 | -$3.82 | -$3.79 |
MBLY lost $4.94 per share over the past year, a bigger loss than the year before.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over MBLY on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
MBLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $492M | -2.4% |
| Q2 2026 | $508M | +0.4% |
| Q1 2026 | $558M | +27% |
| Q4 2025 | $446M | -9% |
| Q3 2025 | $504M | +3.7% |
| Q2 2025 | $506M | +15% |
| Q1 2025 | $438M | +83% |
| Q4 2024 | $490M | -23% |
MBLY's revenue fell from its 2023 peak and has held roughly level since: $492M last quarter, down 2.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -17% | +5 points |
| Q2 2026 | -5.9% | +8.7 points |
| Q1 2026 | -698% | -672 points |
| Q4 2025 | -31% | -14 points |
| Q3 2025 | -22% | +556 points |
| Q2 2025 | -15% | +6.8 points |
| Q1 2025 | -27% | +73 points |
| Q4 2024 | -18% | -29 points |
MBLY has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
MBLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $72M | -50% |
| Q2 2026 | $114M | -43% |
| Q1 2026 | $45M | -53% |
| Q4 2025 | $86M | -55% |
| Q3 2025 | $143M | +38% |
| Q2 2025 | $199M | +3217% |
| Q1 2025 | $95M | +428% |
| Q4 2024 | $191M | +122% |
MBLY has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
MBLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +6M shares |
| 1 year | +1.2% | +10M shares |
| 3 years | +1.7% | +14M shares |
| 5 years | +3.5% | +28.1M shares |
MBLY has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $9.5M |
| Q2 2026 | $23.5M |
| Q4 2025 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | $2M |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MBLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | -202.0x | Net Cash |
| Q1 2023 | -12.5x | Net Cash |
| Q4 2022 | -3.7x | Net Cash |
| Q3 2022 | -2.5x | Net Cash |
| Q2 2022 | 5.8x | High |
| Q1 2022 | -2.3x | Net Cash |
| Q4 2021 | -2.3x | Net Cash |
MBLY has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
MBLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.6 | Oversold |
| Stochastic | 13.5 | Oversold |
MBLY's weekly RSI is 29 (oversold) and its Stochastic is 14 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
MBLY PE vs Consumer Cyclical Sector
MBLY has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
MBLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.71 | 16% below |
| 20 week MA | $7.90 | 29% below |
| 50 week MA | $8.68 | 35% below |
| 100 week MA | $11.9 | 53% below |
| 200 week MA | $21.6 | 74% below |
MBLY is in a downtrend: it's below all five of its weekly moving averages, and 74% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
MBLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $27.0 | $34.0 | +26% |
| 2023 | $34.0 | $43.3 | +27% |
| 2024 | $43.3 | $20.0 | -54% |
| 2025 | $20.0 | $10.4 | -48% |
| 2026 YTD | $10.4 | $5.64 | -46% |
MBLY has the edge over LCID on returns for 2026, with the stronger performance.